Repligen Corp
(NAS:RGEN)
$
154.86
0.16 (0.1%)
Market Cap: 8.68 Bil
Enterprise Value: 8.56 Bil
PE Ratio: 0
PB Ratio: 4.30
GF Score: 94/100 Repligen Corp at Stifel Healthcare Conference Transcript
Nov 15, 2023 / 01:00PM GMT
Release Date Price:
$155.93
(+1.39%)
Daniel Anthony Arias
Stifel, Nicolaus & Company, Incorporated, Research Division - MD & Senior Analyst
Okay. Welcome, everybody, to day 2 of the 2023 Stifel Healthcare Conference. This is a life sciences and diagnostics track. We're happy to kick things off this morning with Repligen. I have CEO, Tony Hunt; and CFO, Jason Garland, with me here. Guys, thanks very much for spending some time this morning.
Anthony J. Hunt
Repligen Corporation - CEO & Director
Good morning.
Jason K. Garland
Repligen Corporation - CFO
Yes. Good to hear.
Questions & Answers
Daniel Anthony Arias;Jason K.
Stifel, Nicolaus & Company, Incorporated, Research Division - MD & Senior Analyst
Jason, maybe since this is our first time getting to chat with you in a public forum, I'll just start with you, if I can. You arrived at the company a couple of months ago. What at a high level would you say you've been spending most of your time focusing on?
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot